📰 Viricides Platform Technology News
Viricides Platform Technology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Viricides Platform Technology. Real-time updates on events, politics, business and more.
April 30, 2024
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed ...
April 30, 2024
SHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that the Phase I Clinical Trial of NV-387 is completed successfully and data lock is expected soon.The Phase 1 clinical trial, protocol number...
February 15, 2024
SHELTON, CT / ACCESSWIRE / February 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly Report on Form 10-Q for the fiscal second quarter ending December 31, 2023 with the Securities and Exch...
November 15, 2023
NanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum ...